Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Radical surgery: Radical nephroureterectomy
Kidney sparing surgery+Postoperative radiotheray: Kidney sparing surgery+Postoperative radiotheray
Study summary
In this study, we propose to conduct an ambispective study to analyze the safety of preserved renal unit surgery combined with postoperative adjuvant radiotherapy in patients with limited stage ureteral cancer with high risk factors, and the efficacy analysis compared with traditional radical surgery. It is hoped that a treatment method that preserves patients' renal function to improve the tolerance of subsequent drug therapy without decreasing the effect of tumor treatment can be achieved in patients with high-risk factors.
Eligibility
Primary outcome measure(s)
- Local recurrence free survival (LRFS) — 1-year, 3-year and 5-year
Local recurrence - Renal Function Indicators — Perioperation and peri-treatment
eGFR, Crea
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Departmeng of Urology, Peking University First Hospital | Beijing | China | Recruiting |
| Department of Radiotherapy Oncology, Peking University First Hospital | Beijing | China | Recruiting |
More Xuesong Li trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06120387 on ClinicalTrials.gov ↗ ← All trials in China